Evidence map›Paper›PMID 28666485›Full record

ArticleArthritis research & therapy2017

Rheumatology in the Middle East in 2017: clinical challenges and research.

Abdulla Watad, Jamal Al-Saleh, Merav Lidar, Howard Amital, Yehuda Shoenfeld

Abstract readEditorial
In one paragraph

Article in Arthritis research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abdulla WatadDepartment of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel.
Jamal Al-SalehRheumatology Unit, Dubai Hospital, Dubai, United Arab Emirates.
Merav LidarRheumatology Unit, Sheba Medical Center, Tel-Hashomer, Israel.
Howard AmitalDepartment of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel.
Yehuda ShoenfeldThe Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, 5265601, Israel. shoenfel@post.tau.ac.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization (WHO) has ranked musculoskeletal diseases among the top ten leading causes of disability in the Middle East. The situation in the Middle East is unique as, although seventeen countries are geographical connected, there is considerable variability in the standard of rheumatology care and research between the countries. There are several factors contributing to this variability: allocated government resources to healthcare services, country demographics, the implemented healthcare system, the number of qualified rheumatologist, political stability, and the immigration to and from these countries.

Indexed as

Biomedical ResearchDeveloping CountriesHealth ServicesHumansMiddle EastRheumatic DiseasesRheumatologyASIA syndromeBehçet’s diseaseFMFIsraelMiddle EastRheumatology

Identifiers

PMID28666485
PMCPMC5493117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.